Clinical Trial Update: A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of food on pharmacokinetics, safety, and tolerability of two different dose combinations of saxagliptin/dapagliflozin/metfor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Saxagliptin (saxagliptin)
• metformin XR (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED